- Bayer (DE:BAYGN)'s (OTCPK:BAYRY) Monsanto (NYSE:MON) insists its Roundup weedkiller is safe, rejecting yesterday's decision by a California jury ordering the company to pay nearly $290M for failing to warn a dying groundskeeper that the product might cause cancer.
- "On the basis of scientific conclusions, the views of worldwide regulatory authorities and the decades-long practical experience with glyphosate use, Bayer is convinced that glyphosate is safe and does not cause cancer," the company says.
- Jurors unanimously found that Monsanto, which says it will appeal, acted with "malice" and that Roundup and the professional grade RangerPro version contributed "substantially" to the man's terminal illness.
- The lawsuit built on 2015 findings by the United Nations' International Agency for Research on Cancer, which classified Roundup's main ingredient glyphosate as a probable carcinogen, causing the state of California to follow suit; Monsanto has consistently disputed the findings.
- Now read: SA Interview: Chris DeMuth Jr. On First United And ETF Reconstitutions
Original article